Summary
A search was made for circulating immune complexes in 42 patients with biopsy-proven lung cancer; sex- and age-matched healthy volunteers were used as normal controls. Two different methods were employed: C1q-binding assay and the conglutinin-binding test. Patients and controls were also examined for delayed hypersensitivity by a skin test using a set of recall antigens. A significant difference was found in the incidence of immune complexes and the response to skin tests between neoplastic subjects and normal controls. However, the incidence of immune complexes was not related to delayed hypersensitivity or the other clinical features investigated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amlot P. L., Pussel B., Stanley J.M.: Correlation between immune complexes and prognostic factors in Hodgkin’s disease - Clin. exp. Immunol.32, 166, 1978.
Baldwin R. W., Embleton M.J., Robins R. A.: Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status - Int. J. Cancer11, 1, 1973.
Baldwin R.W., Harris J. R., Price M. R.: Fractionation of plasma membrane associated tumour-specific antigen from an aminoazo dve-induced rat hepatoma - Int. J. Cancer11, 385, 1973.
Baldwin R. W., Price M. R., Robins R.A.: Blocking of lymphocyte cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes - Nature (Lond.)238, 185, 1972.
Baldwin R. W., Robins R. A.: Humoral factors abrogating cell-mediated immunity in the tumour-bearing host - In: Current topics in microbiology and immunology no. 72. Springer-Verlag, Berlin-Heidelberg-New York, 1975.
Casali P., Bossus A., Carpentier M. A., Lambert P. H.: Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin binding test - Clin. exp. Immunol.29, 342, 1977.
Fujmoto S., Green M., Sehon A. H.: Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts - J. Immunol.116, 791, 1976.
Fujmoto S., Green M., Sehon A.H.: Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts - J. Immunol.116, 800, 1976.
Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr.: Prostaglandin-producing suppressor cells in Hodgkin’s disease - New Engl. J. Med.297, 963, 1977.
Hakala T. R., Lange P.H.: Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract - Science184, 795, 1974.
Hellström L., Hellström K. E.: Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas - Int. J. Cancer4, 587, 1969.
Hellström I., Hellström K.E.: Colony inhibition studies on blocking and non-blocking serum effects in cellular immunity to Moloney sarcomas - Int. J. Cancer5, 195, 1970.
Hellström L., Hellström K. E., Warner G. A.: Increase of lymphocyte-mediated tumor-cell destruction by certain patient sera - Int. J. Cancer12, 348, 1973.
Hellström K. E., Hellström L: Evidence that tumour antigens enhance tumour growthin vivo by interacting with a radiosensitive (suppressor?) cell population - Proc. nat. Acad. Sci. (Wash.)75, 436, 1978.
Hersh E. M., Gutterman J. V., Mavligit G.M.: BCG as adjuvant immunotherapy for neoplasia- Ann. Rev. Med.28, 489, 1977.
Heusser C.M., Boesman M., Nordin J. H., Isliker H.: Effect of chemical and enzymatic radioiodination onin vitro human C1q activities - J. Immunol.110, 820, 1973.
Jose D. G., Seshadri R.: Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity - Int. J. Cancer13, 824, 1974.
Moretta L., Webb S. R., Grossi C. E., Lydyard P.M., Cooper M. D.: Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T-cells bearing receptors for IgM or IgG- J. exp. Med.146, 184, 1977.
Mountain C.F.: The clinical staging of lung cancer - In: I tumori polmonari. Ambrosiana. Milano, 1975; chapt. V, p. 289.
Nelson K., Pollack S. B., Hellström K. E.: Specific anti-tumor responses of cultured immune spleen cells. III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADCC) activities - Int. J. Cancer16, 539, 1975.
Rapport d’un Groupe Scientifique de l’OMS (no. 606): Le rôle des immunocomplexes en pathologie - Organisation Mondiale de la Santé. Série des Rapports Techniques, Genève, 1977.
Shearer W. T., Parker C.H.: Antibody and complement modulation of tumor cell growthin vitro andin vivo - Fed. Proc.37, 2385, 1978.
Sjögren H. O., Hellström I., Bansal S. C., Hellström K. E.: Suggestive evidence that the ’blocking antibodies’ of tumor bearing individuals may be antigen-antibody complexes - Proc. nat. Acad. Sci. (Wash.)68, 1372, 1971.
Sjögren H. O., Hellström I., Bansal S. C., Warner G. A., Hellström K.E.: Elution of blocking factors from human tumors capable of abrogating tumor-cell destruction by specific immune lymphocytes - Int. J. Cancer9, 274, 1972.
Tamerius J., Nepom J., Hellström L., Hellström K. E.: Tumor associated blocking factors: isolation from sera of tumor-bearing mice - J. Immunol.116, 724, 1976.
The T. H., Van Der Giessen M., Huiges H.A., Schraffordt Koops H., Van I.: Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients - Clin. exp. Immunol.32, 387, 1978.
Ting A., Terasaki P. I.: Depressed lymphocyte-mediated killing of sensitized targets in cancer patients- Cancer Res.34, 2694, 1974.
Volanakis J. E., Stroud R. M.: Rabbit C1q: purification and structural studies - J. immunol. Meth.2, 24, 1972.
Zubler R. H., Lange G., Lambert P. H., Miescher P.A.: Detection of immune complexes in unheated sera by a modified123I-C1q binding test - J. Immunol.116, 232, 1976.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tincani, A., Balestrieri, G., Moraschini, A.T. et al. Circulating immune complexes in patients with lung neoplasms. La Ricerca Clin. Lab. 10, 397–403 (1980). https://doi.org/10.1007/BF02905349
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02905349